XENE

Xenon Pharmaceuticals Stock Price

18.51
0.37 (2.04%)
Upgrade to Real-Time
Afterhours (Closed)
18.51

Low
9.32

52 Week Range

High
21.94

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Xenon Pharmaceuticals Inc XENE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.37 2.04% 18.51 18:19:09
Open Price Low Price High Price Close Price Prev Close
18.39 17.71 18.69 18.51 18.14
Bid Price Ask Price Spread News
17.50 22.22 4.72 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,897 134,417 $ 18.47 $ 2,482,388 152,701 9.32 - 21.94
Last Trade Time Type Quantity Stock Price Currency
16:00:19 formt 118 $ 18.51 USD

Xenon Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 758.22M 40.96M 40.00M $ 32.17M $ -27.38M -0.81 -22.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 561.30k 2.00%

more financials information »

Xenon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XENE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.3319.20517.3418.40107,5930.180.98%
1 Month17.4321.5216.9318.98170,9961.086.2%
3 Months15.0321.9414.2819.00198,6733.4823.15%
6 Months11.1921.949.9916.60175,8847.3265.42%
1 Year13.7421.949.3214.46160,4504.7734.72%
3 Years6.1021.945.2512.18164,37812.41203.44%
5 Years6.6721.942.1010.60127,48011.84177.51%

Xenon Pharmaceuticals Description

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.


Your Recent History
NASDAQ
XENE
Xenon Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.